TheEdgeResearch
Home / Stocks / VIT.AX

Vitura Health Limited (VIT.AX)

ASX Healthcare Drug Manufacturers - Specialty & Generic
$0.02 ▼ -7.69%
Market Cap
$15.9M
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
-1.39
52-Wk Range
0.021-0.072
CEO
Justin James
Country
AU
Currency
AUD

Vitura Health Limited operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in South Yarra, VIC, AU. The stock last traded at $0.02, down 7.69% on the session, giving a market capitalisation of $15.9M. Its beta of -1.39 implies it has historically moved less than the broad market.

Company profile
Exchange
Australian Securities Exchange
Employees
72
IPO date
2019-11-06
Headquarters
South Yarra, VIC, AU
About Vitura Health Limited

Established in 2018 and based in South Yarra, Australia, Vitura Health Limited focuses on the supply and marketing of medicinal cannabis goods throughout Australia and the Asian market. The company manages a portfolio of key brands, such as CanView, Burleigh Heads Cannabis, CDA Clinics, Cannadoc, and Adaya. This entity was formerly recognized as Cronos Australia Limited before adopting the name Vitura Health Limited in February 2023.

Comparable companies

Vitura Health Limited is most often compared with the following Healthcare names:

ADO.AXAGN.AXBDX.AXEMD.AXEYE.AXIDT.AXIIQ.AXLGP.AXMAP.AXNXS.AX
More research on VIT.AX
VIT.AX technical analysis VIT.AX TheEdge Score Compare against peers
Open full interactive analysis & DCF →